Login to Your Account

Pharmexa Shares Fall After Breast Cancer Study Halted

By Cormac Sheridan

Wednesday, August 16, 2006
Shares in Pharmexa A/S fell 25 percent on the Copenhagen Stock Exchange Monday on news that the company decided to discontinue recruitment onto a Phase II trial of a therapeutic vaccine for metastatic breast cancer. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription